Benaroya Research Institute Revenue and Competitors

Seattle, WA USA

Location

$5M

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Benaroya Research Institute's estimated annual revenue is currently $42.2M per year.(i)
  • Benaroya Research Institute's estimated revenue per employee is $129,540
  • Benaroya Research Institute's total funding is $5M.

Employee Data

  • Benaroya Research Institute has 326 Employees.(i)
  • Benaroya Research Institute grew their employee count by 0% last year.

Benaroya Research Institute's People

NameTitleEmail/Phone
1
Chief Business DevelopmentReveal Email/Phone
2
ControllerReveal Email/Phone
3
Director, Research Integrity & SafetyReveal Email/Phone
4
Director, Translational Research ProgramReveal Email/Phone
5
HR DirectorReveal Email/Phone
6
Director Finance And AccountingReveal Email/Phone
7
Director, Grants & Contracts AdministrationReveal Email/Phone
8
Director Information TechnologyReveal Email/Phone
9
Chief Administrative Officer, Immune Tolerance NetworkReveal Email/Phone
10
Director, Marketing & CommunicationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.3M2176%N/AN/A
#2
$0.2M30%N/AN/A
#3
$5M546%N/AN/A
#4
$2.1M297%N/AN/A
#5
$0.1M2-33%N/AN/A
#6
$5.1M56-3%N/AN/A
#7
$923.3M64666%N/AN/A
#8
$5.5M605%N/AN/A
#9
$3.8M4615%N/AN/A
#10
$11.3M11112%N/AN/A
Add Company

What Is Benaroya Research Institute?

Benaroya Research Institute at Virginia Mason (BRI) is dedicated to exploring the causes and cures of human disease. Key to this mission is innovation in clinical research. We are committed to staying at the forefront of our changing medical and scientific environments by combining expertise in laboratory investigation with breakthrough research. This bench-to-bedside approach allows for rapid development of scientific findings into medical treatment advancements with the potential to directly benefit people living with disease. BRI\'s state-of-the-art facilities have been designed to offer both patients and researchers the most comfortable and efficient environment in which to conduct clinical trials. Our Clinical Research Center (CRC) in the Virginia Mason Medical Center is committed specifically to providing patients with the best possible treatment and oversight of research procedures - from simple interviews to the most sensitive of care. It is staffed by experienced and caring personnel who are specifically trained in the oversight of clinical trials. The CRC also offers trial participants shorter wait times, a relaxing environment in which to receive care, video and reading libraries, and other amenities to make your visit a relaxing and rewarding one. With hundreds of studies underway, there are many opportunities for both healthy volunteers and people living with disease participate, and help contribute to a cure for diseases such as diabetes, arthritis, cancer, heart disease, and others. Explore our research studies underway to get general information about research projects at BRI, or to find out about opportunities to participate in a clinical research study.

keywords:N/A

$5M

Total Funding

326

Number of Employees

$42.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Benaroya Research Institute News

2022-04-06 - Movers & Shakers, April 8 | BioSpace

Weinreb is a past president of the Association for Research in ... and founder and former Director of the Benaroya Research Institute.

2022-04-06 - Virginia Mason Medical Center Recognized as "LGBTQ+ ...

By bringing together the brightest health care minds through Benaroya Research Institute, a global leader in autoimmune disease and immune...

2022-03-30 - Abata Announces Formation of Advisory Board Comprised of ...

... and Founder and former Director of the Benaroya Research Institute, a leading translational immunology center in Seattle, Washington.

2021-08-16 - GentiBio Raises $157M in Series A Financing

GentiBio, Inc., a Boston, MA-based biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, closed a $157m Series A financing. The round was led by Matrix Capital Management with participation from Avidity Partners, JDRF T1D Fund, OrbiMed, RA Capital Ma ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.4M32617%$294M
#2
$71.3M326-1%N/A
#3
$59.3M32721%N/A
#4
$132.4M3286%N/A
#5
$60.8M33011%$129.4M